|
| Interactions: | Ergometrine Maleate
Adverse Effect: an increased risk of oxytocic toxicity (uterine hyperstimulation) Clinical Management: The concurrent use of dinoprostone with ergonovine is contraindicated. A dosing interval of at least 30 minutes is recommended for the sequential use of oxytocic drugs following the removal of the dinoprostone vaginal insert.
Oxytocin
Adverse Effect: an increased risk of oxytocic toxicity (uterine hyperstimulation) Clinical Management: The concurrent use of dinoprostone with oxytocin is contraindicated. A dosing interval of at least 30 minutes is recommended for the sequential use of oxytocic drugs following the removal of the dinoprostone vaginal insert. |
|
|